Data as of Dec 04
| -0.30 / -0.60%|
The 11 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 53.00, with a high estimate of 60.00 and a low estimate of 44.00. The median estimate represents a +6.70% increase from the last price of 49.67.
The current consensus among 13 polled investment analysts is to Buy stock in AbbVie Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.